⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4047711 | 0.86 | — | — | |
| SCHEMBL1372325 | 0.80 | — | — | |
| SCHEMBL16422811 | 0.80 | — | — | |
| SCHEMBL6081236 | 0.78 | HPGD (0.50) | — | |
| SCHEMBL4422429 | 0.76 | HPGD (0.33) | — | |
| SCHEMBL3176922 | 0.74 | — | — | |
| SCHEMBL15922271 | 0.74 | DAO (0.41) | — | |
| SCHEMBL1522621 | 0.74 | YEATS4 (0.37) | — | |
| SCHEMBL10684316 | 0.73 | TDP1 (0.39) | — | |
| SCHEMBL6377332 | 0.72 | CYP2A6 (0.64) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10752611-B2 | Benzimidazole derivatives | ENANTA PHARMACEUTICALS, INC. (US) | 2020-08-25 | — | — | US | disclosed |
| US-10017499-B2 | Benzimidazole derivatives | ENANTA PHARMACEUTICALS, INC. (US) | 2018-07-10 | — | — | US | disclosed |
| US-10017499-B2 | Benzimidazole derivatives | ENANTA PHARMACEUTICALS, INC. (US) | 2018-07-10 | — | — | US | disclosed |
| US-9765087-B2 | Benzimidazole derivatives | ENANTA PHARMACEUTICALS, INC. (US) | 2017-09-19 | — | — | US | disclosed |
| US-9765087-B2 | Benzimidazole derivatives | ENANTA PHARMACEUTICALS, INC. (US) | 2017-09-19 | — | — | US | disclosed |
| US-20170114046-A1 | NOVEL BENZIMIDAZOLE DERIVATIVES | ENANTA PHARM INC (US) | 2017-04-27 | — | — | US | disclosed |
| US-20170114046-A1 | NOVEL BENZIMIDAZOLE DERIVATIVES | ENANTA PHARM INC (US) | 2017-04-27 | — | — | US | disclosed |
| EP-2400846-B1 | HEPATITIS C VIRUS INHIBITORS | ENANTA PHARM INC (US) | 2016-10-05 | — | — | EP | disclosed |
| US-20140341851-A1 | NOVEL BENZIMIDAZOLE DERIVATIVES | ENANTA PHARMACEUTICALS, INC. (US) | 2014-11-20 | — | — | US | disclosed |
| US-20140341851-A1 | NOVEL BENZIMIDAZOLE DERIVATIVES | ENANTA PHARMACEUTICALS, INC. (US) | 2014-11-20 | — | — | US | disclosed |
| EP-1663254-A2 | ANTI-INFLAMATORY PHOSPHONATE CONJUGATES | GILEAD SCIENCES, INC. (US) | 2006-06-07 | — | — | EP | disclosed |
| US-20060035866-A1 | Phosphonate compounds having immuno-modulatory activity | GILEAD SCIENCES, INC. | 2006-02-16 | — | — | US | disclosed |
| EP-1620110-A2 | IMMUNOMODULATOR PHOSPHONATE CONJUGATES | GILEAD SCIENCES, INC. (US) | 2006-02-01 | — | — | EP | disclosed |
| WO-2004100960-A2 | ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004096236-A2 | IMMUNOMODULATOR PHOSPHONATE CONJUGATES | GILEAD SCIENCES, INC. (US) | 2004-11-11 | — | — | WO | disclosed |
| US-20040180984-A1 | Composition for forming a conjugated polymer pattern and process of forming a conjugated polymer pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2004-09-16 | — | — | US | disclosed |
| EP-0182548-B1 | NOVEL CONDUCTIVE POLYMERS | The British Petroleum Company p.l.c. (GB) | 1990-01-24 | — | — | EP | disclosed |
| US-4808681-A | BATTERY FILMS | THE BRITISH PETROLEUM COMPANY PLC (GB) | 1989-02-28 | — | — | US | disclosed |
| US-4766198-A | POLYMERIZATION OF A BIS-SULFONIUM SALT USING A NITROGEN BASE FOLLOWED BY THERMAL DECOMPOSITION | THE BRITISH PETROLEUM COMPANY P.L.C. (GB) | 1988-08-23 | — | — | US | disclosed |
| EP-0182548-A2 | Novel conductive polymers | The British Petroleum Company p.l.c. (GB) | 1986-05-28 | — | — | EP | disclosed |